How AI can improve drug development probability assessments
Eroom's Law notes drug discovery is slower and costlier, despite tech advances. AI is pivotal in enhancing drug development's probability of technical and regulatory success (PTRS).
This white paper shows how AI improves PTRS assessments, essential for progressing drug candidates. Benefits include:
- Digesting extensive data to detect patterns
- Exceeding traditional methods in prediction
- AI explainability for insight into PTRS
AI in PTRS assessments boosts drug development efficiency, focuses resources on promising candidates, and aids smarter decisions. Learn more in the full white paper.